Benjamin L. Ebert
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 0.02%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Hematology 244
- Acute Myeloid Leukemia Research 199
- Hematopoietic Stem Cell Transplantation 28
- Multiple Myeloma Research and Treatments 14
- Genetics 48
- Myeloproliferative Neoplasms: Diagnosis and Treatment 26
- Blood disorders and treatments 21
- Hemoglobinopathies and Related Disorders 15
- Co-authors
- Todd R. Golub (21 shared papers)Pablo Tamayo (6 shared papers)Michael A. Gillette (2 shared papers)Jill P. Mesirov (2 shared papers)Aravind N. Subramanian (2 shared papers)Vamsi Krishna Mootha (1 shared paper)Scott L. Pomeroy (1 shared paper)Amanda G. Paulovich (1 shared paper)
- Journals
- Blood (118 papers)Cancer Cell (17 papers)Nature (15 papers)Journal of Clinical Oncology (12 papers)Blood Advances (12 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Benjamin L. Ebert
405 papers receiving 117.8k citations
Benjamin L. Ebert's Hit Papers
Peers
Comparison fields: 5 of 193
- Hematology 33.2k
- Cancer Research 16k
- Genetics 9.2k
- Molecular Biology 32.6k
- Oncology 10.7k
Countries citing papers authored by Benjamin L. Ebert
This map shows the geographic impact of Benjamin L. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Ebert more than expected).
Fields of papers citing papers by Benjamin L. Ebert
This network shows the impact of papers produced by Benjamin L. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Ebert. The network helps show where Benjamin L. Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin L. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 419 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Hit paper breakdown → | 2005 | 40048 |
| 2 | MicroRNA expression profiles classify human cancers Hit paper breakdown → | 2005 | 8244 |
| 3 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Hit paper breakdown → | 2016 | 4633 |
| 4 | Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells Hit paper breakdown → | 2013 | 4088 |
| 5 | Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes Hit paper breakdown → | 2014 | 3772 |
| 6 | The landscape of somatic copy-number alteration across human cancers Hit paper breakdown → | 2010 | 3170 |
| 7 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Hit paper breakdown → | 2005 | 2538 |
| 8 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Hit paper breakdown → | 2022 | 2133 |
| 9 | Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease Hit paper breakdown → | 2017 | 2049 |
| 10 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Hit paper breakdown → | 2022 | 1891 |
| 11 | Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes Hit paper breakdown → | 2015 | 1542 |
| 12 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1527 |
| 13 | Clinical Effect of Point Mutations in Myelodysplastic Syndromes Hit paper breakdown → | 2011 | 1349 |
| 14 | Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation Hit paper breakdown → | 2014 | 1275 |
| 15 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Hit paper breakdown → | 2006 | 1198 |
| 16 | Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Hit paper breakdown → | 2010 | 908 |
| 17 | Stem cell gene expression programs influence clinical outcome in human leukemia Hit paper breakdown → | 2011 | 879 |
| 18 | Clonal hematopoiesis in human aging and disease Hit paper breakdown → | 2019 | 829 |
| 19 | Acute myeloid leukemia ontogeny is defined by distinct somatic mutations Hit paper breakdown → | 2014 | 818 |
| 20 | Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis Hit paper breakdown → | 2014 | 753 |
About Benjamin L. Ebert
Benjamin L. Ebert is a scholar working on Hematology, Genetics, Molecular Biology, Cancer Research and Genetics, having authored 419 papers that have together received 119.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (199 papers), Protein Degradation and Inhibitors (40 papers), Hematopoietic Stem Cell Transplantation (28 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (26 papers), Blood disorders and treatments (21 papers), Hemoglobinopathies and Related Disorders (15 papers), Multiple Myeloma Research and Treatments (14 papers) and Cancer, Hypoxia, and Metabolism (14 papers). The work is most often cited by research in Hematology (33.2k citations), Cancer Research (16k citations), Genetics (9.2k citations), Molecular Biology (32.6k citations) and Oncology (10.7k citations). Benjamin L. Ebert has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Todd R. Golub, Pablo Tamayo, Michael A. Gillette, Jill P. Mesirov, Aravind N. Subramanian, Vamsi Krishna Mootha, Scott L. Pomeroy, Amanda G. Paulovich, Sayan Mukherjee and Eric S. Lander. Their work appears in journals such as Blood, Cancer Cell, Nature, Journal of Clinical Oncology and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.